Journal of Pharmacy Practice

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaulin, B.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Pharmacy Practice, Vol. 9, No. 2, 104-112 (1996)
DOI: 10.1177/089719009600900206

Other

The Use of Anticonvulsants in Psychiatry

Bruce Gaulin

The use of anticonvulsants in psychiatry has steadily increased in recent years. Two anticonvulsants in particular, carbamazepine (CBZ) and valproate (VPA), have become commonplace in psychiatric practice for the treatment of bipolar disorder. Schizoaffective dis order and aggression have also been treated with these agents. Indications, pharmacokinetics, drug inter actions, side effects, and monitoring of the anticonvulsants are discussed. Copyright © 1996 by W.B. Saunders Company


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?